Photodynamic Therapy for Nonsubfoveal Choroidal Neovascularization in 100 Eyes With Pathologic Myopia
- 31 January 2007
- journal article
- research article
- Published by Elsevier in American Journal of Ophthalmology
- Vol. 143 (1), 77-82.e2
- https://doi.org/10.1016/j.ajo.2006.09.052
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Verteporfin therapy of subfoveal choroidal neovascularization in pathologic myopiaOphthalmology, 2003
- Pathologic myopia: where are we now?11Internet Advance publication at ajo.com Sept 17, 2002.American Journal of Ophthalmology, 2002
- MyopiaBMJ, 2002
- Photodynamic therapy of subfoveal choroidal neovascularization in pathologic myopia with verteporfinOphthalmology, 2001
- Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization—verteporfin in photodynamic therapy report 2American Journal of Ophthalmology, 2001
- A Preliminary Study of Photodynamic Therapy Using Verteporfin for Choroidal Neovascularization in Pathologic Myopia, Ocular Histoplasmosis Syndrome, Angioid Streaks, and Idiopathic CausesArchives of Ophthalmology (1950), 2000
- Photodynamic Therapy With Verteporfin for Choroidal Neovascularization Caused by Age-related Macular DegenerationArchives of Ophthalmology (1950), 1999
- Age-Specific Prevalence and Causes of Blindness and Visual Impairment in an Older PopulationArchives of Ophthalmology (1950), 1998
- Etiology of Choroidal Neovascularization in Young PatientsOphthalmology, 1996
- Visual Prognosis of Disciform Degeneration in MyopiaOphthalmology, 1983